Literature DB >> 19571163

Thermal hyperalgesia via supraspinal mechanisms in mice lacking glutamate decarboxylase 65.

Kazuhiro Kubo1, Koichi Nishikawa, Junko Ishizeki, Makiko Hardy-Yamada, Yuchio Yanagawa, Shigeru Saito.   

Abstract

Gamma-aminobutyric acid, which is synthesized by two isoforms of glutamate decarboxylase (GAD), inhibits the transfer of nociceptive signals from primary afferent fibers to the central nervous system. However, the roles of a 65-kDa isoform of GAD (GAD65)-mediated GABA in nociceptive processing are less clear. This study tested whether partial reductions in GABAergic inhibitory tone by GAD65 gene knockout [GAD65(-/-)] would contribute to the regulation of pain threshold in mice. Experiments were performed on male wild-type (WT) mice and GAD65(-/-) mice. Acute nociception and inflammatory pain tests were compared between WT mice and GAD65(-/-) mice. GABA(A) receptor-mediated inhibitory postsynaptic currents were also examined by use of the whole-cell patch-clamp method in somatosensory cortical neurons in brain slices. In the hot plate test, which reflects supraspinal sensory integration, a significant reduction in the latency was observed for GAD65(-/-) mice. Intraperitoneal administration of the GABA transporter 1 inhibitor, 1-[2-[[(diphenylmethylene)imino]oxy]ethyl]-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid hydrochloride (C(21)H(22)N(2)O(3).HCl; NO-711), dose-dependently prolonged the latency in both genotypes, suggesting that GABA concentration contributes to acute thermal nociception. However, there was no genotype difference in responses to the tail-immersion test or the von Frey test, indicating that spinal reflex and mechanical nociception are kept intact in GAD65(-/-) mice. There was no genotype difference in responses to chemical inflammatory nociception (formalin test and carrageenan test). Although properties of the phasic component of inhibitory postsynaptic currents were similar in both genotypes, tonic inhibition was significantly reduced in GAD65(-/-) mice. These results support the hypothesis that GAD65-mediated GABA synthesis plays relatively small but significant roles in nociceptive processing via supraspinal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571163     DOI: 10.1124/jpet.109.156034

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  (-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury.

Authors:  Waleed M Renno; May Al-Maghrebi; Muddanna S Rao; Haitham Khraishah
Journal:  J Neurotrauma       Date:  2014-11-10       Impact factor: 5.269

2.  Blocking the GABA transporter GAT-1 ameliorates spinal GABAergic disinhibition and neuropathic pain induced by paclitaxel.

Authors:  Ruchi Yadav; Xisheng Yan; Dylan W Maixner; Mei Gao; Han-Rong Weng
Journal:  J Neurochem       Date:  2015-04-23       Impact factor: 5.372

3.  Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception.

Authors:  Veronika Khariv; Li Ni; Ayomi Ratnayake; Sujitha Sampath; Brianna M Lutz; Xuan-Xiang Tao; Robert F Heary; Stella Elkabes
Journal:  FASEB J       Date:  2016-10-04       Impact factor: 5.191

4.  Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain.

Authors:  Y Wang; M O Nowicki; X Wang; W D Arnold; S A Fernandez; X Mo; J Wechuk; D Krisky; J Goss; D Wolfe; P G Popovich; S Lawler; E A Chiocca
Journal:  Gene Ther       Date:  2012-12-13       Impact factor: 5.250

Review 5.  Transcriptional control of Gad2.

Authors:  Zhizhong Z Pan
Journal:  Transcription       Date:  2012-03-01

6.  After-effects of consecutive sessions of transcranial direct current stimulation (tDCS) in a rat model of chronic inflammation.

Authors:  Gabriela Laste; Wolnei Caumo; Lauren Naomi Spezia Adachi; Joanna Ripoll Rozisky; Isabel Cristina de Macedo; Paulo Ricardo Marques Filho; Wania Aparecida Partata; Felipe Fregni; Iraci L S Torres
Journal:  Exp Brain Res       Date:  2012-07-03       Impact factor: 1.972

7.  Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia.

Authors:  Yumei Chen; Bo Zhu; Hongping Zhang; Ding Ding; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2014-02-03       Impact factor: 3.060

8.  A subconvulsive dose of kainate selectively compromises astrocytic metabolism in the mouse brain in vivo.

Authors:  Anne B Walls; Elvar M Eyjolfsson; Arne Schousboe; Ursula Sonnewald; Helle S Waagepetersen
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-14       Impact factor: 6.200

9.  Glutamic acid decarboxylase 65: a link between GABAergic synaptic plasticity in the lateral amygdala and conditioned fear generalization.

Authors:  Maren D Lange; Kay Jüngling; Linda Paulukat; Marc Vieler; Stefano Gaburro; Ludmila Sosulina; Peter Blaesse; Hari K Sreepathi; Francesco Ferraguti; Hans-Christian Pape
Journal:  Neuropsychopharmacology       Date:  2014-03-25       Impact factor: 7.853

10.  (-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.

Authors:  Waleed M Renno; May Al-Maghrebi; Anwar Al-Banaw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.